{"id":20570,"date":"2022-08-13T07:35:34","date_gmt":"2022-08-13T02:05:34","guid":{"rendered":"https:\/\/johnsonfrancis.org\/general\/?p=20570"},"modified":"2022-10-02T17:42:36","modified_gmt":"2022-10-02T12:12:36","slug":"alirocumab-a-pcsk9-inhibitor-for-high-cholesterol","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/","title":{"rendered":"Alirocumab &#8211; a PCSK9 inhibitor for high cholesterol"},"content":{"rendered":"<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/I9PMXkAxKUc\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<h2><span style=\"color: #008000;\">Alirocumab &#8211; a PCSK9 inhibitor for high cholesterol<\/span><\/h2>\n<p><a href=\"https:\/\/johnsonfrancis.in\/%e0%b4%85%e0%b4%b2%e0%b4%bf%e0%b4%b1%e0%b5%8b%e0%b4%95%e0%b5%81%e0%b4%ae%e0%b4%be%e0%b4%ac%e0%b5%8d-%e0%b4%89%e0%b4%af%e0%b5%bc%e0%b4%a8%e0%b5%8d%e0%b4%a8-%e0%b4%95%e0%b5%8a%e0%b4%b3%e0%b4%b8\/\">\u0d05\u0d32\u0d3f\u0d31\u0d4b\u0d15\u0d41\u0d2e\u0d3e\u0d2c\u0d4d: \u0d09\u0d2f\u0d7c\u0d28\u0d4d\u0d28 \u0d15\u0d4a\u0d33\u0d38\u0d4d\u0d1f\u0d4d\u0d30\u0d4b\u0d33\u0d3f\u0d28\u0d41\u0d33\u0d4d\u0d33 \u0d2a\u0d41\u0d24\u0d3f\u0d2f \u0d36\u0d15\u0d4d\u0d24\u0d2e\u0d3e\u0d2f \u0d2e\u0d30\u0d41\u0d28\u0d4d\u0d28\u0d4d<\/a><\/p>\n<p>Alirocumab is a human monoclonal antibody to an enzyme known in short as PCSK9. Alirocumab is used to treat high cholesterol which is not controlled by diet and statin therapy. Those with statin intolerance will also benefit from this drug. The function of PCSK9 is to bind to LDL cholesterol receptors on liver cells and promote their degradation. The reduction of LDL cholesterol receptors leads to increase in levels of LDL cholesterol. Hence inhibition of PCSK9 by drugs like alirocumab can produce marked reduction of LDL cholesterol levels.<\/p>\n<p>Those with high risk from diseases due to fat deposition in blood vessels and those with high levels of LDL cholesterol due to genetic defects may benefit from this medication. Those who do not achieve target LDL cholesterol levels with maximally tolerated doses of statins alone or in combination with other cholesterol lowering agents are considered for this expensive medication.\u00a0The medication is available as prefilled syringes or pens, to be given once in two weeks as injection under the skin. The medication has to be stored in a refrigerator.<\/p>\n<p>Most important downside of the medication is the high cost at present, which might come down later. Another downside is that it has to be given as injections and small number of persons can have injection site reactions. Flu-like illness is another potential problem which has been noted in some. Due caution is needed like any other new medication which has not been in use for a long time in large number of persons. Some rare adverse effects might surface only on long term use in large number of persons, which only time can tell.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alirocumab &#8211; a PCSK9 inhibitor for high cholesterol \u0d05\u0d32\u0d3f\u0d31\u0d4b\u0d15\u0d41\u0d2e\u0d3e\u0d2c\u0d4d: \u0d09\u0d2f\u0d7c\u0d28\u0d4d\u0d28 \u0d15\u0d4a\u0d33\u0d38\u0d4d\u0d1f\u0d4d\u0d30\u0d4b\u0d33\u0d3f\u0d28\u0d41\u0d33\u0d4d\u0d33 \u0d2a\u0d41\u0d24\u0d3f\u0d2f \u0d36\u0d15\u0d4d\u0d24\u0d2e\u0d3e\u0d2f \u0d2e\u0d30\u0d41\u0d28\u0d4d\u0d28\u0d4d Alirocumab is a human monoclonal antibody to an enzyme known in short as PCSK9. Alirocumab is used to treat high cholesterol which is not controlled by diet and statin therapy. Those with statin intolerance will also benefit from this drug. The [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":20572,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[7],"tags":[],"class_list":["post-20570","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alirocumab - a PCSK9 inhibitor for high cholesterol - All About Heart And Blood Vessels<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alirocumab - a PCSK9 inhibitor for high cholesterol - All About Heart And Blood Vessels\" \/>\n<meta property=\"og:description\" content=\"Alirocumab &#8211; a PCSK9 inhibitor for high cholesterol \u0d05\u0d32\u0d3f\u0d31\u0d4b\u0d15\u0d41\u0d2e\u0d3e\u0d2c\u0d4d: \u0d09\u0d2f\u0d7c\u0d28\u0d4d\u0d28 \u0d15\u0d4a\u0d33\u0d38\u0d4d\u0d1f\u0d4d\u0d30\u0d4b\u0d33\u0d3f\u0d28\u0d41\u0d33\u0d4d\u0d33 \u0d2a\u0d41\u0d24\u0d3f\u0d2f \u0d36\u0d15\u0d4d\u0d24\u0d2e\u0d3e\u0d2f \u0d2e\u0d30\u0d41\u0d28\u0d4d\u0d28\u0d4d Alirocumab is a human monoclonal antibody to an enzyme known in short as PCSK9. Alirocumab is used to treat high cholesterol which is not controlled by diet and statin therapy. Those with statin intolerance will also benefit from this drug. The [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Heart And Blood Vessels\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-13T02:05:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-02T12:12:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/general\/wp-content\/uploads\/2022\/08\/Alirocumab-\u2013-a-PCSK9-inhibitor-for-high-cholesterol.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"678\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/#\\\/schema\\\/person\\\/f35ea33ecf9c9923597de2691ebed1a7\"},\"headline\":\"Alirocumab &#8211; a PCSK9 inhibitor for high cholesterol\",\"datePublished\":\"2022-08-13T02:05:34+00:00\",\"dateModified\":\"2022-10-02T12:12:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\\\/\"},\"wordCount\":289,\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/Alirocumab-\u2013-a-PCSK9-inhibitor-for-high-cholesterol.jpg\",\"articleSection\":[\"General\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\\\/\",\"name\":\"Alirocumab - a PCSK9 inhibitor for high cholesterol - All About Heart And Blood Vessels\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/Alirocumab-\u2013-a-PCSK9-inhibitor-for-high-cholesterol.jpg\",\"datePublished\":\"2022-08-13T02:05:34+00:00\",\"dateModified\":\"2022-10-02T12:12:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/#\\\/schema\\\/person\\\/f35ea33ecf9c9923597de2691ebed1a7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/Alirocumab-\u2013-a-PCSK9-inhibitor-for-high-cholesterol.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/Alirocumab-\u2013-a-PCSK9-inhibitor-for-high-cholesterol.jpg\",\"width\":1200,\"height\":678},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alirocumab &#8211; a PCSK9 inhibitor for high cholesterol\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/\",\"name\":\"All About Heart And Blood Vessels\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/#\\\/schema\\\/person\\\/f35ea33ecf9c9923597de2691ebed1a7\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alirocumab - a PCSK9 inhibitor for high cholesterol - All About Heart And Blood Vessels","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/","og_locale":"en_US","og_type":"article","og_title":"Alirocumab - a PCSK9 inhibitor for high cholesterol - All About Heart And Blood Vessels","og_description":"Alirocumab &#8211; a PCSK9 inhibitor for high cholesterol \u0d05\u0d32\u0d3f\u0d31\u0d4b\u0d15\u0d41\u0d2e\u0d3e\u0d2c\u0d4d: \u0d09\u0d2f\u0d7c\u0d28\u0d4d\u0d28 \u0d15\u0d4a\u0d33\u0d38\u0d4d\u0d1f\u0d4d\u0d30\u0d4b\u0d33\u0d3f\u0d28\u0d41\u0d33\u0d4d\u0d33 \u0d2a\u0d41\u0d24\u0d3f\u0d2f \u0d36\u0d15\u0d4d\u0d24\u0d2e\u0d3e\u0d2f \u0d2e\u0d30\u0d41\u0d28\u0d4d\u0d28\u0d4d Alirocumab is a human monoclonal antibody to an enzyme known in short as PCSK9. Alirocumab is used to treat high cholesterol which is not controlled by diet and statin therapy. Those with statin intolerance will also benefit from this drug. The [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/","og_site_name":"All About Heart And Blood Vessels","article_published_time":"2022-08-13T02:05:34+00:00","article_modified_time":"2022-10-02T12:12:36+00:00","og_image":[{"width":1200,"height":678,"url":"https:\/\/johnsonfrancis.org\/general\/wp-content\/uploads\/2022\/08\/Alirocumab-\u2013-a-PCSK9-inhibitor-for-high-cholesterol.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/general\/#\/schema\/person\/f35ea33ecf9c9923597de2691ebed1a7"},"headline":"Alirocumab &#8211; a PCSK9 inhibitor for high cholesterol","datePublished":"2022-08-13T02:05:34+00:00","dateModified":"2022-10-02T12:12:36+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/"},"wordCount":289,"image":{"@id":"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/general\/wp-content\/uploads\/2022\/08\/Alirocumab-\u2013-a-PCSK9-inhibitor-for-high-cholesterol.jpg","articleSection":["General"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/","url":"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/","name":"Alirocumab - a PCSK9 inhibitor for high cholesterol - All About Heart And Blood Vessels","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/general\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/general\/wp-content\/uploads\/2022\/08\/Alirocumab-\u2013-a-PCSK9-inhibitor-for-high-cholesterol.jpg","datePublished":"2022-08-13T02:05:34+00:00","dateModified":"2022-10-02T12:12:36+00:00","author":{"@id":"https:\/\/johnsonfrancis.org\/general\/#\/schema\/person\/f35ea33ecf9c9923597de2691ebed1a7"},"breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/general\/wp-content\/uploads\/2022\/08\/Alirocumab-\u2013-a-PCSK9-inhibitor-for-high-cholesterol.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/general\/wp-content\/uploads\/2022\/08\/Alirocumab-\u2013-a-PCSK9-inhibitor-for-high-cholesterol.jpg","width":1200,"height":678},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/general\/alirocumab-a-pcsk9-inhibitor-for-high-cholesterol\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/general\/"},{"@type":"ListItem","position":2,"name":"Alirocumab &#8211; a PCSK9 inhibitor for high cholesterol"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/general\/#website","url":"https:\/\/johnsonfrancis.org\/general\/","name":"All About Heart And Blood Vessels","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/general\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/johnsonfrancis.org\/general\/#\/schema\/person\/f35ea33ecf9c9923597de2691ebed1a7","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/general\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/posts\/20570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/comments?post=20570"}],"version-history":[{"count":5,"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/posts\/20570\/revisions"}],"predecessor-version":[{"id":20732,"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/posts\/20570\/revisions\/20732"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/media\/20572"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/media?parent=20570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/categories?post=20570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/tags?post=20570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}